Insmed (INSM) Competitor Comparison
We are evaluating the key criteria listed to compare Insmed (INSM) against its competitors in the Biotechnology industry.
Market Capitalization
39 / 368Gross Profits
33 / 278Total Revenue
43 / 300EBITDA
331 / 337Free Cashflow
344 / 352Quick Ratio
208 / 357Earnings per Share
310 / 359Dividend yield
0 / 6Total Cash
35 / 358Performance 3 years
43 / 368Performance 5 years
36 / 368Performance 10 years
24 / 368Linearity 3 years
345 / 368Linearity 5 years
343 / 368Linearity 10 years
353 / 368Total Rank
161 / 368Dividend Rank
165 / 368Valuation Rank
303 / 368Piotroski Rank
133 / 368Muliplier Rank
368 / 368Total Revenue - INSM ranking 43 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.